Bell Investment Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.53K Hold
26
– – ﹤0.01% 1430
2026
Q1
$838 Hold
26
– – ﹤0.01% 1593
2025
Q4
$1.09K Hold
26
– – ﹤0.01% 1523
2025
Q3
$893 Hold
26
– – ﹤0.01% 1582
2025
Q2
$703 Hold
26
– – ﹤0.01% 1684
2025
Q1
$771 Hold
26
– – ﹤0.01% 1636
2024
Q4
$1.03K Sell
26
-18
-41% -$682 ﹤0.01% 1574
2024
Q3
$1.5K Hold
44
– – ﹤0.01% 1460
2024
Q2
$954 Hold
44
– – ﹤0.01% 1622
2024
Q1
$976 Hold
44
– – ﹤0.01% 1612
2023
Q4
$1.21K Sell
44
-36
-45% -$869 ﹤0.01% 1528
2023
Q3
$1.79K Buy
80
+18
+29% +$463 ﹤0.01% 1328
2023
Q2
$1.58K Sell
62
-21
-25% -$509 ﹤0.01% 1409
2023
Q1
$1.85K Buy
83
+2
+2% +$48 ﹤0.01% 1309
2022
Q4
$1.92K Buy
81
+45
+125% +$1.05K ﹤0.01% 1316
2022
Q3
$1K Buy
+36
New +$810 ﹤0.01% 1620
2021
Q4
– Sell
-15
Closed -$1K – 1951
2021
Q3
$1K Buy
+15
New +$655 ﹤0.01% 1599

Other funds holding VCYT

Bell Investment Advisors's VCYT Position: Q2 2026 in Review

Bell Investment Advisors held its Veracyte (VCYT) position steady in Q2 2026 at 26 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Bell Investment Advisors first reported a position in VCYT in Q3 2021 and has held it in 17 quarters since. The position peaked at $1.92K in Q4 2022. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Bell Investment Advisors held 26 shares of Veracyte worth $1.53K as of Q2 2026.
  • Bell Investment Advisors left its Veracyte share count unchanged in Q2 2026.
  • Veracyte made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1430 holding.
  • Bell Investment Advisors first reported a position in Veracyte in Q3 2021 and has held it in 17 quarters since.
  • Bell Investment Advisors's Veracyte position peaked at $1.92K in Q4 2022.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.